Multidrug and extensively drug resistant tuberculosis (MDR/XDR-TB) remains a serious threat to TB control worldwide. Portugal registers a high number of MDR-TB and XDR-TB cases particularly in Lisbon, the capital city.
Perdigão, João +3 more
core
Newer research transforming 24-month treatment of MDR/XDR-TB TO 6 months. [PDF]
Jain N, Sharma D, Jain NK.
europepmc +1 more source
Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities. [PDF]
Chin KL +6 more
europepmc +1 more source
Population structure and emergence of resistance to new and repurposed drugs in XDR-TB: insights from a 10-year genomic study in the Western Cape, South Africa review. [PDF]
Ngom JT +8 more
europepmc +1 more source
Autologous Human Dendritic Cells from XDR-TB Patients Polarize a Th1 Response Which Is Bactericidal to Mycobacterium tuberculosis. [PDF]
Londt R +7 more
europepmc +1 more source
A Cross-Sectional, Descriptive Qualitative Study of Information Counselling During Tuberculosis Treatment in South Africa: Awareness of XDR-TB Patients on Ototoxic Effects. [PDF]
Arendse SM, Khoza-Shangase K.
europepmc +1 more source
Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB. [PDF]
Nonghanphithak D +5 more
europepmc +1 more source
Evaluation of Sulfasalazine as an Adjunctive Therapy in Treating Pulmonary Pre-XDR-TB: Efficacy, Safety, and Treatment Implication. [PDF]
Fu L +12 more
europepmc +1 more source
Human mpox co-infection with advanced HIV-1 and XDR-TB in a MSM patient previously vaccinated against smallpox: A case report. [PDF]
Fang Y +14 more
europepmc +1 more source

